Navigation Links
FDA Accepts Ranexa(R) sNDA and NDA for Filing
Date:11/19/2007

PALO ALTO, Calif., Nov 19 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. (Nasdaq: CVTX) announced today that the U.S. Food and Drug Administration (FDA) has notified the Company that its supplemental new drug application (sNDA) and new drug application (NDA) for Ranexa(R) (ranolazine extended- release tablets) have both been accepted for filing. The Prescription Drug User Fee Act (PDUFA) action date for both applications is July 27, 2008.

The sNDA seeks an expansion to the approved product labeling for Ranexa(R) (ranolazine extended-release tablets) to include a first line angina indication and a significant reduction in cautionary language. The sNDA is being reviewed by the FDA Division of Cardiovascular Renal Products.

After receiving this sNDA submission from CV Therapeutics, the FDA initiated, and has now accepted for filing, a separate NDA on behalf of the Company to provide a clinical review of a potential labeling change to add reduction of hemoglobin A1c (HbA1c) in coronary artery disease patients with diabetes. This NDA is being reviewed by the FDA Division of Metabolism and Endocrinology Products.

"With the Ranexa sNDA and NDA now accepted for filing, the NDA under review for regadenoson and our marketing authorization application for ranolazine under review in Europe, we are very excited to have several major applications in process and are looking forward to multiple potential approvals in 2008," said Louis G. Lange, CV Therapeutics chairman and chief executive officer.

In accordance with a special protocol assessment agreement between the FDA and CV Therapeutics, the Company believes that data from the MERLIN TIMI-36 study could support expansion of the existing Ranexa indication
'/>"/>

SOURCE CV Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. FDA Accepts ISO-Vorin(TM) New Drug Application Amendment Submitted by Spectrum Pharmaceuticals
2. FDA Accepts Sucampos sNDA for Lubiprostone (8 mcg) for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C)
3. Ranexa(R) Added to New ACC/AHA Guidelines on Unstable Angina/Non ST-Elevation Myocardial Infarction (UA/NSTEMI)
4. Circulation Publishes MERLIN TIMI-36 Data Showing Safety and Anti-Arrhythmic Effects of Ranexa(R)
5. CV Therapeutics Submits Supplemental New Drug Application for Ranexa(R) (ranolazine extended-release tablets)
6. European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreichs Ataxia by Santhera
7. Barr Confirms Filing an Application With a Paragraph IV Certification for Femcon(R) FE Chewable Oral Contraceptive Product
8. Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology
9. 3 strikes, youre out? Refiling of Amendment to Change Constitution to Criminalize Stem Cell Cures Shows Trouble with Anti-Cures Cause
10. Prana Announces Filing of Annual Report
11. AMDL Announces Filing of Extension on Third Quarter 2007 Form 10-QSB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... BioConvergence team members Curtis Strother ... 2013’s BioLogistics Summit in San Francisco earlier this ... Chain IQ and IQPC, addressed the increasingly complex ... part, attributed to current trends of globalization, outsourcing, ... trends is an increase in movement, which is ...
(Date:6/19/2013)... Toronto, Canada (PRWEB) June 19, 2013 ... clinical trial business can potentially be worth up ... With this opportunity, the Indian government is taking ... clinical trials the process. , This presentation will ... clinical trial regulations ,     Immediate and long ...
(Date:6/19/2013)... Austin, TX (PRWEB) June 19, 2013 ... new application report that details the measurement of sulfur ... NEX QC+ high resolution benchtop EDXRF analyzer . ... with standard test method ISO 13032. This International ... method for the determination of sulfur content in automotive ...
(Date:6/19/2013)... 2013 A new look at “big ... other trends will highlight technical sessions at SPIE ... In its 33rd year, the three-day event is the ... key suppliers, approximately 100 technical presentations and numerous networking ... society for optics and photonics , the meeting will ...
Breaking Biology Technology:BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment 2Rigaku Publishes New Application Note for Analysis of ULSD Per ISO 13032 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 3
... Back... -- BEIJING, Aug. 24 /PRNewswire-Asia/ -- ... ... ... // Results are keyed by longUrl, so we need to grab the first one. for (var ...
... found a material in which an electric field can control ... magnetoelectric effect discovered by the Rutgers group can be extended ... magnetic bits in ultra high-density data storage. The research appears ... The researchers found the effect by studying the magnetic ...
... global leader in material science and high-performance polymer extrusions, ... languages: English, Chinese, French, German, Japanese, and Spanish. Zeus ... Managers and modified customer support hours to better accommodate ... download at http://www.zeusinc.com . "Publishing ...
Cached Biology Technology:Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives 2Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives 3Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives 4Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives 5Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives 6Zeus Catalog Available in Six Languages 2
(Date:6/16/2013)... India reduce rates of syphilis, HIV and other sexually ... found. , About two million Indians are ... Andhra Pradesh, Karnataka, Maharashtra and Tamil Nadu. The study, ... Dalla Lana School of Public Health and St. Michael,s ... impact of prevention among female sex workers whose contact ...
(Date:6/16/2013)... cells use to group together and move around the body ... the first time by scientists at UCL. , Published ... on the process that occurs when cancer cells interact with ... metastasis. Scientists know that cancer cells recruit healthy cells and ... takes place and how it could be controlled to design ...
(Date:6/15/2013)... to treat osteoporosis has now been shown to stop ... that have become resistant to current targeted therapies, according ... presented June 15, 2013, at the annual Endocrine Society ... packs a powerful one-two punch that not only prevents ... flags the estrogen receptor for destruction. , "We found ...
Breaking Biology News(10 mins):HIV prevention among female sex workers in India reduces HIV and syphilis 2'Chase and run' cell movement mechanism explains process of metastasis 2Osteoporosis drug stops growth of breast cancer cells, even in resistant tumors 2
... biologists working on guppies small freshwater fish that ... that rapid growth responses to increased food availability after ... repercussions in adulthood. Based on their experiments, the ... juveniles produced fewer offspring than usual. Study results ...
... robots routinely operate on patients at most major hospitals, ... from that scenario -- the doctor. Feasibility studies ... robot -- without any human assistance -- can locate ... guide a device to the lesion and take multiple ...
... Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is setting up ... cooperation among researchers. This decision was taken by the ... of the organisation,s annual plenary meeting in Berlin. The ... opportunity to address current and urgent issues in their ...
Cached Biology News:Rapid growth in adolescence leads to fewer offspring, UC Riverside biologists find 2Rapid growth in adolescence leads to fewer offspring, UC Riverside biologists find 3Next generation surgical robots: Where's the doctor? 2Next generation surgical robots: Where's the doctor? 36 new research units established 26 new research units established 3
Sheep polyclonal to Melatonin ( Abpromise for all tested applications). Antigen: Melatonin Tg conjugate....
Goat polyclonal to DDDDK tag (FITC) ( Abpromise for all tested applications)....
...
DNA fragmentation factor & Inhibitor of CAD...
Biology Products: